Key Points Pfizer's deal with the U.S. government, a robust pipeline, and a reasonable valuation make it a compelling buy. Eli Lilly's fantastic financial results and impressive innovative abilities paint a bright picture for the future. 10 stocks we like better than Pfizer › There are several compelling reasons to invest in pharmaceutical companies, especially when the economy isn't doing well. Since they belong to a defensive industry, drugmakers tend to perform better than most companies even in ...